P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway

Experimental Hematology

Volumn 33, Issue 1, 2005, Pages 62-72

  Turzanski, Julie ^a   Grundy, Martin ^a   Shang, Shilli ^a   Russell, Nigel ^a   Pallis, Monica ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7 AMINODACTINOMYCIN; CERAMIDE; CYCLOSPORIN A; ELACRIDAR; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; GLYCOPROTEIN P; LACTOSYLCERAMIDE; PROPIDIUM IODIDE; RHODAMINE 123; URIDINE DIPHOSPHATE GLUCOSE;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL CYCLE; CELL VIABILITY; CONTROLLED STUDY; CYTOFLUOROMETRY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GOLGI COMPLEX; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ACUTE DISEASE; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CERAMIDES; GLUCOSYLCERAMIDES; GLUCOSYLTRANSFERASES; GOLGI APPARATUS; HUMANS; LEUKEMIA, MYELOID; P-GLYCOPROTEIN;

EID: 12344336357     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.10.005     Document Type: Article

References (62)

1. G. Del Poeta, R. Stasi, and G. Aronica Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia Blood 87 1996 1997 2004
2. V. Nussler, R. Pelka-Fleischer, and H. Zwierzina P-glycoprotein expression in patients with acute leukemia - clinical relevance Leukemia 10 1996 S23 S31
3. F.J. Sharom The P-glycoprotein efflux pump: how does it transport drugs? J Membr Biol 160 1997 161 175
4. R.W. Johnstone, A.A. Ruefli, K.M. Tainton, and M.J. Smyth A role for P-glycoprotein in regulating cell death Leuk Lymphoma 38 2000 1 11
5. M. Pallis, and N. Russell P-glycoprotein expression is associated with resistance to spontaneous in vitro apoptosis in AML [letter] Leukemia 13 1999 1468 1469
6. M. Pallis, and N. Russell P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway Blood 95 2000 2897 2904
7. M. Pallis, J. Turzanski, Y. Higashi, and N. Russell P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype Leuk Lymphoma 43 2002 1221 1228
8. M.J. Smyth, E. Krasovskis, V.R. Sutton, and R.W. Johnstone The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis Proc Natl Acad Sci U S A 95 1998 7024 7029
9. R. Johnstone, E. Cretney, and M. Smyth P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death Blood 93 1999 1075 1085
10. L.J. Robinson, W.K. Roberts, T.T. Ling, D. Lamming, S.S. Sternberg, and P.D. Roepe Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts Biochemistry 36 1997 11169 11178
11. M. Pallis, J. Turzanski, M. Grundy, C. Seedhouse, and N. Russell Resistance to spontaneous apoptosis in AML blasts is associated with p-glycoprotein exression and function, but not with the presence of FLT3 internal tandem duplications Br J Haematol 120 2003 1009 1016
12. W.J. Van Blitterswijk, A.H. Van Der Luit, R.J. Veldman, M. Verheij, and J. Borst Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J 369 2003 199 211
13. K. Hofmann, and V. Dixit Ceramide in apoptosis - does it really matter? TIBS 23 1998 374 377
14. K. Mengubas, F.A. Riordan, and C.A. Bravery Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism Oncogene 18 1999 2499 2506
15. Y.A. Hannun, and L.M. Obeid Mechanisms of ceramide-mediated apoptosis Advances In Experimental Medicine and Biology 407 1997 145 149
16. S. Jayadev, B. Liu, and A.E. Bielawska Role for ceramide in cell cycle arrest J Biol Chem 270 1995 2047 2052
17. B.J. Pettus, C.E. Chalfant, and Y.A. Hannun Ceramide in apoptosis: an overview and current perspectives Biochim Biophys Acta 1585 2002 114 125
18. W.D. Jarvis, R.N. Kolesnick, F.A. Fornari, R.S. Traylor, D.A. Gewirtz, and S. Grant Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway Proc Natl Acad Sci U S A 91 1994 73 77
19. L. Ji, G. Zhang, S. Uematsu, Y. Akahori, and Y. Hirabayashi Induction of apoptotic dna fragmentation and cell-death by natural ceramide FEBS Lett 358 1995 211 214
20. S. Geley, B.L. Hartmann, and R. Kofler Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA FEBS Lett 400 1997 15 18
21. C.E. Connor, J. Burrows, A.C. Hearps, G.M. Woods, R.M. Lowenthal, and S.J. Ragg Cell cycle arrest of hematopoietic cell lines after treatment with ceramide is commonly associated with retinoblastoma activation Cytometry 43 2001 164 169
22. R. Bose, M. Verhij, A. Haimovitz-Friedman, K. Scotto, Z. Fuks, and R. Kolesnick Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating cell death signals Cell 82 1995 405 414
23. J.P. Jaffrezou, T. Levade, and A. Bettaieb Daunorubicin-induced apoptosis - triggering of ceramide generation through sphingomyelin hydrolysis EMBO J 15 1996 2417 2424
24. Y.A. Hannun Functions of ceramide in coordinating cellular-responses to stress Science 274 1996 1855 1859
25. J.P. Jaffrezou, N. Maestre, V. deMasMansat, C. Bezombes, T. Levade, and G. Laurent Positive feedback control of neutral sphingomyelinase activity by ceramide FASEB J 12 1998 999 1006
26. Y.Y. Liu, T.Y. Han, A.E. Giuliano, and M.C. Cabot Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells J Biol Chem 274 1999 1140 1146
27. Y.Y. Liu, T.Y. Han, J.Y. Yu, and A. Bitterman Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells J Lipid Res 45 2004 933 940
28. D. Jeckel, A. Karrenbauer, K.N. Burger, G. van Meer, and F. Wieland Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions J Cell Biol 117 1992 259 267
29. H. Lannert, K. Gorgas, I. Meissner, F.T. Wieland, and D. Jeckel Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi J Biol Chem 273 1998 2939 2946
30. 6-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis J Biol Chem 275 2000 6246 6251
31. Y. Lavie, H. Cao, S.L. Bursten, A.E. Giuliano, and M.C. Cabot Accumulation of glucosylceramides in multidrug-resistant cancer cells J Biol Chem 271 1996 19530 19536
32. J.A. Shayman, G.D. Deshmukh, and S. Mahdiyoun Modulation of renal epithelial cell growth by glucosylceramide. Association with protein kinase C, sphingosine, and diacylglycerol J Biol Chem 266 1991 22968 22974
33. A. Spinedi, S.D. Bartolomeo, and M. Piacentini Apoptosis induced by N-hexanoylsphingosine in CHP-100 cells associates with accumulation of endogenous ceramide and is potentiated by inhibition of glucocerebroside synthesis Cell Death Differ 5 1998 785 791
34. K.M. Nicholson, D.M. Quinn, G.L. Kellett, and J.R. Warr Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase Br J Cancer 81 1999 423 430
35. Y.Y. Liu, T.Y. Han, A.E. Giuliano, N. Hansen, and M.C. Cabot Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance J Biol Chem 275 2000 7138 7143
36. Y.Y. Liu, T.Y. Han, A.E. Giuliano, and M.C. Cabot Ceramide glycosylation potentiates cellular multidrug resistance FASEB J 15 2001 719 730
37. R.S. Olshefski, and S. Ladisch Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity Int J Cancer 93 2001 131 138
38. R.J. Veldman, A. Mita, and O. Cuvillier The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs FASEB J 17 2003 1144 1146
39. A. van Helvoort, A.J. Smith, and H. Sprong MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine Cell 87 1996 507 517
40. M.F. De Rosa, D. Sillence, C. Ackerley, and C. Lingwood Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis J Biol Chem 279 2004 7867 7876
41. J.A. Shabbits, and L.D. Mayer P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs Mol Cancer Ther 1 2002 205 213
42. Y. Lavie, H. Cao, and A. Volner Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells J Biol Chem 272 1997 1682 1687
43. M.M. van den Heuvel-Eibrink, E.A. Wiemer, and M.J. de Boevere MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia Blood 97 2001 3605 3611
44. M. Pallis, J. Turzanski, S. Langabeer, and N.H. Russell Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts Adv Exp Med Biol 457 1999 77 88
45. P. Ferrao, P. Sincock, S. Cole, and L. Ashman Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia Leuk Res 25 2001 395 405
46. M. Ormerod Investigating the relationship between the cell cycle and apoptosis using flow cytometry J Immunol Methods 265 1992 73 80
47. R.J. Veldman, E.-I. Pecheur, S.C.D. van Ijzendoorn, J.W. Kok, and D. Hoekstra Cell lipids: from isolation to functional dynamics J. Davey Essential Cell Biology: A Practical Approach 2003 Oxford Oxford University Press
48. M. Pallis, J. Syan, and N.H. Russell Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34 Cytometry 37 1999 308 313
49. A. Molinari, A. Calcabrini, and S. Meschini Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells Int J Cancer 75 1998 885 893
50. N.G. Lipsky, and R.E. Pagano Intracellular translocation of fluorescent sphingolipids in cultured fibroblasts: endogenously synthesized sphingomyelin and glucocerebroside analogues pass through the Golgi apparatus en route to the plasma membrane J Cell Biol 100 1985 27 34
51. R.M. Guasch, C. Guerri, and J.E. O'Connor Study of surface carbohydrates on isolated Golgi subfractions by fluorescent-lectin binding and flow cytometry Cytometry 19 1995 112 118
52. A. van Helvoort, M.L. Giudici, M. Thielemans, and G. van Meer Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity J Cell Sci 110 1997 75 83
53. R.J. Veldman, K. Klappe, and J. Hinrichs Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus FASEB J 16 2002 1111 1113
54. L.L. Cooling, S. Zhang De, S.J. Naides, and T.A. Koerner Glycosphingolipid expression in acute nonlymphocytic leukemia: common expression of shiga toxin and parvovirus B19 receptors on early myeloblasts Blood 101 2003 711 721
55. R. De Maria, L. Lenti, and F. Malisan Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis Science 277 1997 1652 1655 [published erratum appears in Science 1998 Apr 17;280(5362):363]
56. A. Abe, N.S. Radin, and J.A. Shayman Induction of glucosylceramide synthase by synthase inhibitors and ceramide Biochim Biophys Acta 1299 1996 333 341
57. R.J. Veldman, H. Sietsma, K. Klappe, D. Hoekstra, and J.W. Kok Inhibition of P-glycoprotein activity and chemosensitization of multidrug-resistant ovarian carcinoma 2780AD cells by hexanoylglucosylceramide Biochem Biophys Res Commun 266 1999 492 496
58. P. Borst, N. Zelcer, and A. van Helvoort ABC transporters in lipid transport Biochim Biophys Acta 1486 2000 128 144
59. A. Lucci, W.I. Cho, T.Y. Han, A.E. Giuliano, D.L. Morton, and M.C. Cabot Glucosylceramide: a marker for multiple-drug resistant cancers Anticancer Res 18 1998 475 480
60. C. Bezombes, N. Maestre, G. Laurent, T. Levade, L. Bettaieb, and J.-P. Jaffrezou Restoration of TNF-α-induced ceramide generation and apoptosis in resistant leukemia KG1a cells by the p-glycoprotein blocker PSC833 FASEB J 12 1998 101 109
61. M. Itoh, T. Kitano, and M. Watanabe Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia Clin Cancer Res 9 2003 415 423
62. I. Plo, G. Lehne, K.J. Beckstrom, and Maestre Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells Mol Pharmacol 62 2002 304 312